NCT06723821View on ClinicalTrials.gov

Noninvasive Neuromodulation in the Management of Post-COVID Musculoskeletal Pain

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 15, 2024

Primary Completion Date

October 15, 2025

Study Completion Date

November 15, 2025

Conditions
COVID-19Musculoskeletal Pain
Interventions
OTHER

Neuromodulation group

During the 12 sessions of which the treatment consists in applying 60 minutes of microcurrent in low intensity.

OTHER

Neuromodulation sham group

During the 12 sessions of which the treatment consists in applying 60 minutes of sham microcurrent in low intensity.

Trial Locations (1)

28805

RECRUITING

Centro Investigación Fisioterapia y Dolor, Alcalá de Henares

All Listed Sponsors
lead

University of Alcala

OTHER